Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT-774312 in Bilateral Nasal Polyposis
NCT03688555Phase 2Completed
- Sponsor
- Idorsia
- Start
- Oct 2018
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in nasal polyps comparing ACT-774312 with Placebo (2 arms). Primary endpoint: Change From Baseline to Week 12 in Nasal Polyp Score. Started Oct 2018; status: completed.
02
Drugs
ACT-774312
03
Conditions
nasal polyps
Beyond the preview
Go deeper on NCT03688555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03688555.